⌕
Tema Oncology ETF · CANC · Nasdaq
Broad equity exposure · not Tenet-scored
Compare
$38.86−1.67%At close
$38.86−0.66 (−1.67%)
At close: Nov 18, 2026, 4:00 PM ET· Nasdaq · USD

CANC Holdings

CANC holds 57 positions as of Nov 18, 2026; the largest are GMAB at 6.1%, LLY at 5.7% and RVMD at 5.2%.

Sources Fund holdings disclosures Fund disclosuresHoldings as of How we compute thisNot investment advice
Positions
57
as of Nov 18, 2026
Largest holding
GMAB 6.1%
One position carries outsized weight. Check it fits your view.
Top-10 share
45.9%
Concentrated — its ten largest names are ~46% of the fund.

Weights exclude the cash/collateral sleeve (0.5%).

All 57 holdings

#TickerCompanyWeightCumulative · to 100.0%
1GMABGENMAB A/S6.1%
6.1%
2LLYELI LILLY & CO5.7%
11.8%
3RVMDREVOLUTION MEDICINES INC5.2%
17.0%
4MRKMERCK & CO INC5.1%
22.1%
5ONCBEONE MEDICINES LTD4.5%
26.6%
6COGTCOGENT BIOSCIENCES INC4.3%
30.9%
7NOVN.SWNOVARTIS AG4.3%
35.2%
8EXELEXELIXIS INC3.9%
39.1%
9ABBVABBVIE INC3.5%
42.6%
10RHHBYROCHE HOLDING AG3.3%
45.9%
11BBIOBRIDGEBIO PHARMA INC3.3%
49.2%
12CGONCG ONCOLOGY INC3.2%
52.4%
13HALOHALOZYME THERAPEUTICS INC3.0%
55.3%
14BMYBRISTOL-MYERS SQUIBB CO2.8%
58.1%
15ELVNENLIVEN THERAPEUTICS INC2.8%
60.9%
16AZN.LASTRAZENECA PLC2.5%
63.4%
17JNJJOHNSON & JOHNSON2.4%
65.8%
18RLAYRELAY THERAPEUTICS INC2.1%
67.9%
19AMGNAMGEN INC2.0%
70.0%
20IMNMIMMUNOME INC2.0%
72.0%
21IDYAIDEAYA BIOSCIENCES INC2.0%
74.0%
22ERASERASCA INC1.9%
75.9%
23ZLABZAI LAB LTD1.8%
77.7%
24IOVAIOVANCE BIOTHERAPEUTICS INC1.7%
79.5%
25LEGNLEGEND BIOTECH CORP1.6%
81.1%
26ZYMEZYMEWORKS INC1.3%
82.5%
27CELCCELCUITY INC1.3%
83.8%
28SMMTSUMMIT THERAPEUTICS INC1.1%
84.9%
29REPLREPLIMUNE GROUP INC1.1%
86.0%
30GILDGILEAD SCIENCES INC1.1%
87.1%
31NUVBNUVATION BIO INC0.8%
88.0%
32GHGUARDANT HEALTH INC0.8%
88.8%
33URGNUROGEN PHARMA LTD0.8%
89.6%
34CRVSCORVUS PHARMACEUTICALS INC0.8%
90.3%
35RCUSARCUS BIOSCIENCES INC0.7%
91.1%
36KURAKURA ONCOLOGY INC0.7%
91.8%
37NTRANATERA INC0.7%
92.5%
38IMCRIMMUNOCORE HOLDINGS PLC0.7%
93.1%
39INBXINHIBRX BIOSCIENCES INC0.5%
93.7%
40IBRXIMMUNITYBIO INC0.5%
94.2%
41VSTMVERASTEM INC0.5%
94.7%
42ANLADLAI NORTYE GROUP LTD0.5%
95.2%
43CASH & CASH EQUIVALENTS0.5%
95.6%
44IMTXIMMATICS NV0.5%
96.1%
45ORICORIC PHARMACEUTICALS INC0.5%
96.5%
46ANABANAPTYSBIO INC0.4%
97.0%
47TNGXTANGO THERAPEUTICS INC0.4%
97.4%
48SLSSELLAS LIFE SCIENCES GROUP INC0.4%
97.8%
49OLMAOLEMA ONCOLOGY INC0.3%
98.1%
50JANXJANUX THERAPEUTICS INC0.3%
98.4%
51TYRATYRA BIOSCIENCES INC0.3%
98.7%
52CGEMCULLINAN THERAPEUTICS INC0.3%
99.0%
53CTMXCYTOMX THERAPEUTICS INC0.2%
99.2%
54CADLCANDEL THERAPEUTICS INC0.2%
99.5%
55ARVNARVINAS INC0.2%
99.7%
56BCAXBICARA THERAPEUTICS INC0.2%
99.8%
57AUTLAUTOLUS THERAPEUTICS PLC0.1%
100.0%

What are CANC's top holdings?

CANC's five largest holdings as of Nov 18, 2026 are GMAB at 6.1%, LLY at 5.7%, RVMD at 5.2%, MRK at 5.1% and ONC at 4.5%.

How many holdings are in CANC?

CANC holds 57 positions as of Nov 18, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.